Figure 3.
Computed tomography scans of liver (A) and thorax (B) taken in September 2008, 12 mo after initiation of sorafenib therapy showing a dramatic regression of previously described tumor lesions.
Computed tomography scans of liver (A) and thorax (B) taken in September 2008, 12 mo after initiation of sorafenib therapy showing a dramatic regression of previously described tumor lesions.